Update on age-appropriate preventive measures and screening for Canadian primary care providers

T Shimizu, M Bouchard, C Mavriplis - Canadian Family Physician, 2016 - cfp.ca
Objective To summarize the best available age-appropriate, evidence-based guidelines for
prevention and screening in Canadian adults. Quality of evidence The Canadian Task Force …

[HTML][HTML] Post-treatment adverse health correlates among prostate cancer survivors in a sample of men residing in Atlantic Canada

G Ilie, R Rutledge, E Sweeney - Current Oncology, 2021 - mdpi.com
Background: Recent large population-based studies have shed light on an association
between prostate cancer (PCa) survivorship and mental health, which emerged when the …

Raman spectroscopy and supervised learning as a potential tool to identify high‐dose‐rate‐brachytherapy induced biochemical profiles of prostate cancer

K Milligan, SJ Van Nest, X Deng… - Journal of …, 2022 - Wiley Online Library
Abstract High‐dose‐rate‐brachytherapy (HDR‐BT) is an increasingly attractive alternative to
external beam radiation‐therapy for patients with intermediate risk prostate cancer. Despite …

[HTML][HTML] Can you un-ring the bell? A qualitative study of how affect influences cancer screening decisions

SM Driedger, G Annable, M Brouwers, D Turner… - BMC cancer, 2017 - Springer
Background The belief that early detection is the best protection against cancer underlies
cancer screening. Emerging research now suggests harms associated with early detection …

[HTML][HTML] Prostate-specific antigen testing for prostate cancer screening: A national survey of Canadian primary care physicians' opinions and practices

MG Goldenberg, SC Skeldon, M Nayan… - Canadian Urological …, 2017 - ncbi.nlm.nih.gov
Methods Twenty PCPs piloted the survey to assess its accessibility. We distributed a flyer to
19 633 PCPs as an insert in a large mailed package inviting them to attend a national …

[HTML][HTML] Getting (along) with the guidelines: reconciling patient autonomy and quality improvement through shared decision making

Y Xu, PS Wells - Academic Medicine, 2016 - journals.lww.com
In past decades, stark differences in practice pattern, cost, and outcomes of care across
regions with similar health demographics have prompted calls for reform. As health systems …

[HTML][HTML] Prediction of disease progression indicators in prostate cancer patients receiving HDR-brachytherapy using Raman spectroscopy and semi-supervised …

K Milligan, X Deng, R Ali-Adeeb, P Shreeves… - Scientific Reports, 2022 - nature.com
This work combines Raman spectroscopy (RS) with supervised learning methods—group
and basis restricted non-negative matrix factorisation (GBR-NMF) and linear discriminant …

Male Oncology Research and Education program for men at high risk for prostate cancer

J Lorentz, SK Liu, D Vesprini - Current Oncology, 2018 - mdpi.com
Male Oncology Research and Education program for men at high risk for prostate cancer Page
1 MALE ONCOLOGY RESEARCH AND EDUCATION PROGRAM, Lorentz et al. 170 Current …

Developing the Breast Utility Instrument to assess health-related quality of life and preferences in patients with breast cancer

TCO Tsui - 2022 - search.proquest.com
Breast cancer (BrC) is the most common cancer in women worldwide, however no BrC-
specific preference-based instrument exists. BrC and its treatments can impact patients' …

Arrogance of 'but all you need is a good index finger': A narrative ethics exploration of lack of universal funding of PSA screening in Canada

J Nisker - Journal of medical ethics, 2020 - jme.bmj.com
This narrative ethics exploration stems from my happy prostate-specific antigen (PSA) story,
though it should not have been, as I annually refuse my family physician's recommendation …